NB

Nicholas Bayless

Chief Technology Officer

Centivax

Stanford, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Centivax
Industry
biotechnology
Employees
26.0
Seniority
C suite
Annual Revenue
3000000.0
Total Funding
15194875.0
Latest Funding
Seed

Technologies

Gmail Google Apps YouTube Squarespace ECommerce WordPress.org Mobile Friendly Typekit IoT Node.js Android Render Micro Python Circle Remote AI

Keywords

broad-spectrum vaccines universal vaccines covid-19 therapeutics antibody programs anti-wound pathogen antibodies multidrug-resistant bacteria pre-clinical development clinical trials gates foundation grand challenge antibody neutralization antigen design immune response pathogen prevention vaccine technology immuno-oncology dna vaccines inflammatory diseases vaccine development infectious diseases medical research biomedical innovation therapeutic antibodies clinical research vaccine efficacy immunotherapy healthcare solutions disease prevention immune engineering pathogen resistance research collaborations clinical partnerships public health preventive medicine vaccine strategy cellular therapies autoimmunity treatments biotherapeutics pandemic preparedness antibody engineering infection control scientific advisory biotech startup translational research vaccine safety epidemiological studies research & development clinical applications vaccine delivery systems health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans